A randomised clinical trial of antiseptic nasal carrier cream and silver nitrate cautery in the treatment of recurrent anterior epistaxis

Clinical Otolaryngology and Allied Sciences

Volumn 24, Issue 3, 1999, Pages 228-231

  Murthy, P ^a   Nilssen, E L K ^a   Rao, S ^a   McClymont, L G ^a  

^a RAIGMORE HOSPITAL   (United Kingdom)

Author keywords

Antispetic cream; Cautery; Epistaxis; Treatment

Indexed keywords

ANTIINFECTIVE AGENT; NASEPTIN; SILVER NITRATE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CAUTERIZATION; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EPISTAXIS; FEMALE; GROUPS BY AGE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, TOPICAL; ADULT; ANTI-INFECTIVE AGENTS, LOCAL; CAUTERY; CHLORHEXIDINE; DRUG COMBINATIONS; EMULSIONS; EPISTAXIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NEOMYCIN; QUESTIONNAIRES; RECURRENCE; SILVER NITRATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 0033012892     PISSN: 03077772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2273.1999.00236.x     Document Type: Article

References (15)

1. 1 SHAHEEN O.H. (1987). Epistaxis, Scott Brown's Otolaryngology, Vol. 4, 5th edn (KERR A.G. & GROVES J., eds), pp. 272-282. Butterworths, London
2. 2 RODEGHIERO F., CASTAMAN G. & DINI E. (1987). Epidemiological investigation of the prevalence of von Willebrand's disease. Blood 69, 454-459
3. 3 JOSEPHSON G.D., GODLEY F.A. & STIERNA P. (1991) Practical management of epistaxis. Med. Clin. North. Am. 75, 1311-1320
4. 4 BARK G.D. (1989) Silver nitrate cautery and epistaxis. Arch. Emerg. Med. 6, 233
5. 5 RANDALL D.A., FREEMAN S.B. (1991). Management of anterior and posterior epistaxis. Am. Fam. Physician 43, 2007-2014
6. 6 PARKER A.J. & CLEGG R.T. (1990). How to control epistaxis. Br. J. Hosp Med. 44, 198-200
7. 7 WURMAN L.H., SACK J.G., FLANNERY J.V. & LIPSMAN R.A. (1992). The management of epistaxis. Am. J. Otolaryngol. 13, 193-209
8. 8 MURTHY P. & LAING M.R. (1996). An unusual severe adverse reaction to silver nitrate cautery for epistaxis in an immunocompromised patient. Rhinology 34, 186-187
9. 9 MAYALL F. & WILD D. (1996). A silver tatoo of the nasal mucosa after silver nitrate cautery. J. Laryngol. Otol. 110, 609-610
10. 10 KREMPL G.A. & NOORILY A.D. (1995). Use of oxymetazoline in the management of epistaxis. Ann. Otol. Rhinol. Laryngol. 104, 704-706
11. 11 JASH D.K. (1973). Epistaxis: topical use of epsilon-aminocaproic acid in its management. J. Laryngol. Otol. 87, 895-898
12. 12 LETHAGEN S. & RAGNARSON TENNVALL G. (1993). Self-treatment with desmopressin intranasal spray in patients with bleeding disorders: effect on bleeding symptoms and socio-economic factors. Ann. Hematol. 66, 257-260
13. 13 TIBBELIN A., AUST. R., BENDE M. et al. (1995). Effect of local tranexamic acid gel in the treatment of epistaxis. ORL 57, 207-209
14. 14 RUDDY J., PROOPS D.W., PEARMAN K. et al. (1991). Management of epistaxis in children. Int. J. Pediatr. Otorhinolaryngol. 21, 139-142
15. 15 BARELLI P.A. (1977). The management of epistaxis in children. Otolaryngol. Clin. North Am. 10, 91-93